Qintao Lai - Publications

Human cytomegalovirus reactivation in cirrhosis patients with acute decompensation.

Journal: Clinical and molecular hepatology

Published: March 25, 2025

Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis.

Journal: Clinical and molecular hepatology

Published: July 29, 2024

Artificial Liver Support System Improves One-Year Prognosis of Patients With Hepatitis B Virus-Associated Acute-on-Chronic Liver Failure.

Journal: Journal of gastroenterology and hepatology

Published: July 24, 2024

Spleen-dedicated stiffness measurement performed well to rule out high-risk varices in HBV-related hepatocellular carcinoma: Screening for high-risk varices in HCC.

Journal: Alimentary pharmacology & therapeutics

Published: October 23, 2023

Combined model with acoustic radiation force impulse to rule out high-risk varices in HBV-related cirrhosis with viral suppression.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: November 17, 2022

Baveno VII algorithm outperformed other models in ruling out high-risk varices in individuals with HBV-related cirrhosis.

Journal: Journal of hepatology

Published: June 29, 2022

Prognostic and therapeutic significance of microbial cell-free DNA in plasma of people with acute decompensation of cirrhosis.

Journal: Journal of hepatology

Published: April 09, 2022

Baveno VI criteria and spleen stiffness measurement rule out high-risk varices in virally suppressed HBV-related cirrhosis.

Journal: Journal of hepatology

Published: June 08, 2020

Scavenger receptor A impairs interferon response to HBV infection by limiting TRAF3 ubiquitination through recruiting OTUB1.

Journal: The FEBS journal

Published: January 30, 2019

Upregulation of NKG2C+ natural killer cells, TLR-2 expression on monocytes and downregulation of regulatory T-cells influence PEG-IFN treatment efficacy in entecavir-suppressed patients with CHB.

Journal: Antiviral therapy

Published: March 12, 2015

Involvement of soluble scavenger receptor A in suppression of T cell activation in patients with chronic hepatitis B.

Journal: BMC immunology

Published: September 16, 2014

TCRγδ(+)CD4(-)CD8(-) T cells suppress the CD8(+) T-cell response to hepatitis B virus peptides, and are associated with viral control in chronic hepatitis B.

Journal: PloS one

Published: September 08, 2013